tiprankstipranks
Trending News
More News >
Global Cord Blood Corporation (CORBF)
:CORBF
US Market

Global Cord Blood (CORBF) Income Statement

Compare
176 Followers

Global Cord Blood Income Statement

Last quarter (Q4 2021), Global Cord Blood's total revenue was ¥297.38M, a decrease of -5.84% from previous quarter. In Q4, Global Cord Blood's net income was ¥104.78M. See Global Cord Blood’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
¥ 1.24B¥ 1.12B¥ 1.24B¥ 988.48M¥ 888.26M
Gross Profit
¥ 1.06B¥ 934.04M¥ 1.03B¥ 785.20M¥ 701.09M
Operating Expenses
¥ 451.08M¥ 406.54M¥ 465.43M¥ 402.88M¥ 435.71M
Depreciation and Amortization
¥ 47.92M¥ 49.99M¥ 52.69M¥ 52.46M¥ 47.97M
EBITDA
¥ 656.79M¥ 3.90B¥ 4.31B¥ 2.92B¥ 2.25B
Operating Income
¥ 608.87M¥ 527.50M¥ 568.78M¥ 382.32M¥ 265.37M
Other Income/Expenses
¥ 18.97M¥ 63.78M¥ 20.12M¥ -169.40M¥ -1.47B
Pretax Income
¥ 627.84M¥ 591.28M¥ 588.90M¥ 357.08M¥ 287.82M
Net Income
¥ 501.06M¥ 492.04M¥ 478.92M¥ 291.63M¥ 224.82M
Per Share Metrics
Basic EPS
¥ 4.12¥ 4.07¥ 3.97¥ 2.42¥ 2.01
Diluted EPS
¥ 4.12¥ 4.07¥ 3.97¥ 2.42¥ 1.89
Weighted Average Shares Outstanding
121.55M 121.55M 121.55M 121.27M 112.94M
Weighted Average Shares Outstanding (Diluted)
121.55M 121.55M 121.55M 121.42M 119.33M
Currency in CNY

Global Cord Blood Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis